Factors that predict survival in patients with cirrhosis considered for liver transplantation

M Samada Suarez1, J C Hernández Perera, L Ramos Robaina

  • 1Centro de Investigaciones Médico Quirúrgicas, Havana, Cuba. marcia.samada@infomed.sld.cu

Transplantation Proceedings
|November 18, 2008
PubMed

Insights

Child-Pugh classification is a key predictor of survival for liver transplant candidates. Stage C and high MELD scores indicate poorer outcomes, guiding transplant evaluations.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Clinical Prognostics

Background:

  • Liver transplantation is a critical treatment for end-stage liver disease.
  • Accurate prognostic tools are essential for patient selection and management.
  • Existing scoring systems like Child-Pugh (CP) and Model for End-Stage Liver Disease (MELD) are used to assess liver function and predict outcomes.

Purpose of the Study:

  • To determine prognostic factors for 6- and 12-month survival in patients evaluated for liver transplantation.
  • To compare the predictive value of Child-Pugh classification and MELD score for patient survival.

Main Methods:

  • A cohort of 144 cirrhosis patients evaluated for liver transplantation was analyzed.
  • Clinical and laboratory variables, including CP classification and MELD score, were recorded.
  • Statistical analysis, including Cox regression, was performed to identify significant predictors of survival.

Main Results:

  • Univariate analysis identified several factors associated with survival, including CP classification and MELD score.
  • Cox regression analysis revealed Child-Pugh classification as the sole independent predictor of survival.
  • Worse survival at 6 and 12 months was associated with CP stage C and MELD scores > 15.

Conclusions:

  • Child-Pugh classification is an independent prognostic factor for liver transplant recipient survival.
  • CP stage C and MELD scores > 15 are strongly linked to reduced survival.
  • Both CP classification and MELD score are crucial for evaluating liver transplant candidates.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...